Site rotation isnt just about comfort
This may improve adherence, reduce treatment fatigue, and help integrate chronic obesity management more seamlessly into a patient's daily life, much like taking a daily pill for hypertension or dyslipidemia
Starting Dose: 0.5mg weekly (weeks 1-4) Escalation: 1mg (weeks 5-8), 2mg (weeks 9-12), 4mg (weeks 13-20), 8mg (weeks 21+) Injection Site: Abdomen, rotating sides weekly Timing: Sunday mornings, same time each week Protein Target: 140-160g daily View Product Understanding Retatrutide: The Triple-Agonist Difference The Reality of Obesity in Young Men Clinical Data for Young Adults: What the Trials Show How Retatrutide Works in the Male Body Are You a Good Candidate
This eating pattern matches the medications mechanism instead of fighting it
Updated February 2026 Retatrutide vs Wegovy: Triple Agonist vs GLP-1 Retatrutide produces nearly double the weight loss of Wegovy, but Wegovy is available now with proven cardiovascular protection